Skip to content

Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS)

Study of the Effectiveness of Internet Delivered Cognitive Behavior Therapy in a Sample of Consecutively Recruited Patients Diagnosed With Irritable Bowel Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00844961
Enrollment
61
Registered
2009-02-16
Start date
2008-11-30
Completion date
2011-02-28
Last updated
2011-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

IBS, CBT, Internet treatment, Cognitive behavior therapy

Brief summary

The study will recruit 80 out-patients diagnosed with Irritable Bowel Syndrome from a gastroenterological clinic. The recruitment will be consecutive with all patients receiving the diagnosis being offered to participate. After recruitment and 3 week baseline measure of IBS symptoms they will be randomised to either 10 weeks of internet delivered CBT or waiting list. After treatment IBS-symptoms are measured again to assess treatment effectiveness. All patients on waiting list are offered the same treatment as patients randomised to treatment. All patients are assessed 12 months after completion of treatment. Patients in treatment condition are hypothesized to experience significant reduction IBS symptoms and quality of life compared to patients on waiting list.

Interventions

BEHAVIORALInternet delivered cognitive behavior therapy

10 weeks of internet delivered cognitive behavior therapy targeted at reducing experience of IBS symptoms and improving quality of life. Patients are offered guidance via email by a therapist.

Sponsors

Allmänna arvsfonden
CollaboratorUNKNOWN
Region Stockholm
CollaboratorOTHER_GOV
Königska-Söderströmska sjukhemmet
CollaboratorUNKNOWN
Aleris Helse
CollaboratorOTHER
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Irritable Bowel Syndrome according to Rome III criteria

Exclusion criteria

* History of inflammatory bowel disease (IBD) * Symptom debut after age of 50 * Ongoing severe mental illness (psychosis, severe depression, suicidal ideation, bipolar disease) * Inability to participate in internet delivered treatment

Design outcomes

Primary

MeasureTime frame
The Gastrointestinal Symptom Rating Scale - IBS Version (GSRS-IBS)Before treatment

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026